Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Montelukast to Treat the Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

NCT04714515 is registered in ClinicalTrials.gov with University of Sargodha as lead sponsor.

NCT NCT04714515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04714515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Montelukast to Treat the Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Lead sponsor
University of Sargodha
Phase
Observational
Overall status
Completed
Start date
February 20, 2020
Completion date
April 20, 2020
Enrollment
150 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, sars-cov-2 infection